20,915 Shares in Synopsys, Inc. $SNPS Bought by Maytree Asset Management Ltd

Key Points

• Maytree Asset Management acquired a new stake of 20,915 shares of Synopsys (≈$9.82 million) in Q4, making the stock about 7.3% of Maytree’s portfolio and its 5th largest holding.
• Institutional ownership is high at 85.47%, with major investors like Vanguard, State Street, Victory Capital and Capital Research materially increasing their SNPS positions in recent quarters.
• Synopsys beat Q results (EPS $3.77 vs. $3.56 expected; revenue $2.41B, +65.6% YoY), issued FY2026 EPS guidance of 14.38–14.46, and carries a MarketBeat consensus rating of Hold with an average price target of $531.00.

Maytree Asset Management Ltd acquired a new stake in Synopsys, Inc. (NASDAQ:SNPS - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 20,915 shares of the semiconductor company's stock, valued at approximately $9,824,000. Synopsys comprises about 7.3% of Maytree Asset Management Ltd's investment portfolio, making the stock its 5th biggest position.

Several other large investors have also added to or reduced their stakes in SNPS. Vanguard Group Inc. boosted its position in shares of Synopsys by 1.6% during the 4th quarter. Vanguard Group Inc. now owns 18,464,862 shares of the semiconductor company's stock worth $8,673,315,000 after purchasing an additional 283,677 shares in the last quarter. State Street Corp grew its holdings in Synopsys by 20.6% during the third quarter. State Street Corp now owns 8,760,358 shares of the semiconductor company's stock worth $4,322,273,000 after buying an additional 1,493,912 shares in the last quarter. Victory Capital Management Inc. raised its holdings in shares of Synopsys by 238.8% in the third quarter. Victory Capital Management Inc. now owns 2,824,349 shares of the semiconductor company's stock valued at $1,393,506,000 after purchasing an additional 1,990,608 shares during the last quarter. Capital Research Global Investors increased its stake in Synopsys by 226.6% in the 3rd quarter. Capital Research Global Investors now owns 2,524,512 shares of the semiconductor company's stock valued at $1,245,533,000 after buying an additional 1,751,432 shares during the last quarter. Finally, Van ECK Associates Corp boosted its position in Synopsys by 15.3% in the third quarter. Van ECK Associates Corp now owns 2,216,908 shares of the semiconductor company's stock worth $1,093,800,000 after purchasing an additional 293,784 shares during the last quarter. Institutional investors and hedge funds own 85.47% of the company's stock.

Synopsys Price Performance

Shares of SNPS stock opened at $502.51 on Wednesday. The firm has a market capitalization of $96.26 billion, a P/E ratio of 78.03, a P/E/G ratio of 4.06 and a beta of 1.25. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.26 and a current ratio of 1.36. Synopsys, Inc. has a 52-week low of $376.18 and a 52-week high of $651.73. The stock has a 50 day moving average price of $431.32 and a 200 day moving average price of $446.18.

Synopsys (NASDAQ:SNPS - Get Free Report) last released its quarterly earnings data on Wednesday, February 25th. The semiconductor company reported $3.77 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.56 by $0.21. The firm had revenue of $2.41 billion for the quarter, compared to the consensus estimate of $2.39 billion. Synopsys had a net margin of 13.76% and a return on equity of 6.83%. The company's quarterly revenue was up 65.6% on a year-over-year basis. During the same period last year, the firm earned $3.03 earnings per share. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. As a group, sell-side analysts predict that Synopsys, Inc. will post 10.3 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on SNPS shares. The Goldman Sachs Group set a $600.00 target price on shares of Synopsys and gave the company a "buy" rating in a report on Wednesday, February 25th. Needham & Company LLC reaffirmed a "buy" rating on shares of Synopsys in a research note on Thursday, February 26th. Weiss Ratings restated a "hold (c)" rating on shares of Synopsys in a report on Thursday, January 22nd. Wells Fargo & Company dropped their target price on shares of Synopsys from $500.00 to $450.00 and set an "equal weight" rating on the stock in a report on Thursday, February 26th. Finally, Rosenblatt Securities reduced their price objective on shares of Synopsys from $560.00 to $530.00 and set a "buy" rating for the company in a research note on Thursday, February 26th. Eight investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $531.00.

Synopsys Company Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.